Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × abemaciclib × Clear all

Sponsor

Conditions

Breast Neoplasms 21 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Neoplasms 3 Sarcoma, Ewing 2 Glioblastoma 2 Brain Neoplasms 2 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Metastatic Castration-Resistant Prostate Cancer 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Hormone Receptor Positive Breast Cancer 1 Glioma 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

Trastuzumab 2 valrubicin 1 niraparib 1 enfortumab vedotin 1 avelumab 1 Surveys and Questionnaires 1 Sunitinib 1 Sugammadex 1 Standard of Care 1 Paclitaxel 1 Neostigmine 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡